Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the optimal follow-up for systemic sclerosis patients: study protocol for a Dutch multicenter randomized controlled trial.

Trials·2026
Same author

High-dimensional, outcome-dependent missing data problems: Models for the human <math></math> loci.

Statistical methods in medical research·2025
Same author

Competing Risk Models Should Be Considered When Estimating Kidney Allograft Failure.

Journal of the American Society of Nephrology : JASN·2025
Same author

Risk Prediction of Implant Loss following Implant-Based Breast Reconstruction: A Population-Based Study.

Plastic and reconstructive surgery·2024
Same author

Association between muscle mass, visceral adiposity, and histologic tumor stromal features in colon cancer.

Clinical nutrition ESPEN·2024
Same author

Smooth Hazards With Multiple Time Scales.

Statistics in medicine·2024

Related Experiment Video

Updated: Mar 28, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K

A prediction model for progressive disease in systemic sclerosis.

Jessica Meijs1, Anne A Schouffoer2, Nina Ajmone Marsan3

  • 1Department of Rheumatology , Leiden University Medical Center , Leiden , The Netherlands.

RMD Open
|December 22, 2015
PubMed
Summary

A new model helps predict short-term progressive disease in systemic sclerosis (SSc) patients. Key indicators like friction rubs and muscle weakness can double the predicted risk, guiding clinical management.

Keywords:
EpidemiologySystemic SclerosisTreatment

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.7K

Related Experiment Videos

Last Updated: Mar 28, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.7K

Area of Science:

  • Rheumatology
  • Pulmonology
  • Clinical Prediction Modeling

Background:

  • Systemic sclerosis (SSc) is a complex autoimmune disease with significant morbidity and mortality.
  • Accurate short-term risk assessment is crucial for timely clinical management and intervention in SSc patients.
  • Existing models may not fully capture the rapid progression seen in some SSc cases.

Purpose of the Study:

  • To develop and validate a predictive model for short-term progressive disease in patients with systemic sclerosis (SSc).
  • To identify key clinical parameters associated with disease progression in SSc.
  • To aid clinicians in guiding management strategies for SSc.

Main Methods:

  • Evaluation of baseline characteristics and 1-year follow-up data from 163 SSc patients.
  • Definition of progressive disease included mortality, significant decline in lung function (FVC, DLCO), body weight, renal function (eGFR), and worsening of skin score (mRSS) or functional status (HAQ).
  • Univariable and multivariable logistic regression analyses were employed to identify predictors; model performance was assessed using calibration plots and AUC.

Main Results:

  • 63 out of 163 patients experienced progressive disease, with 8 deaths within 18 months.
  • Multivariable analysis identified friction rubs, proximal muscular weakness, and decreased maximum oxygen uptake (% predicted) as significant predictors of progression, independent of age, gender, and immunosuppressive use.
  • The prediction model demonstrated a substantial increase in predicted risk, from 37% pre-test to 67-89% post-test.

Conclusions:

  • A novel prediction model effectively identifies SSc patients at high risk for short-term disease progression.
  • Friction rubs, proximal muscular weakness, and reduced maximum oxygen uptake are key clinical markers for predicting SSc progression.
  • This model can potentially double the estimated risk for progressive disease in individual SSc patients, informing clinical decisions.